Medical Weight Loss: Provider-Supervised GLP-1 Therapy and Metabolic Health

Obesity is a chronic, relapsing disease associated with type 2 diabetes, cardiovascular disease, sleep apnea, and other conditions. Medically supervised weight management combines lifestyle intervention with pharmacotherapy when appropriate.

Patient Evaluation

• BMI, waist circumference, and weight history
• Screening for diabetes or prediabetes, dyslipidemia, hypertension, fatty liver disease, and sleep apnea
• Review of medications that may promote weight gain
• Assessment of contributors such as thyroid disease, sleep, stress, and eating patterns
• Screening for contraindications to specific agents

GLP-1 Receptor Agonist Therapy

GLP-1 receptor agonists and related agents are FDA-approved for chronic weight management and/or type 2 diabetes in appropriate patients. In clinical trials, they have produced clinically significant weight loss when combined with diet and physical activity.

Clinical Considerations:

• Eligibility: Labeled indications are based on BMI thresholds and weight-related conditions.
• Titration: Gradual dose escalation helps manage gastrointestinal side effects such as nausea, constipation, or diarrhea.
• Contraindications and warnings: Review personal or family history of medullary thyroid carcinoma or MEN 2, pancreatitis history, gallbladder disease, and pregnancy plans.
• Lean mass: Adequate protein intake and resistance training are recommended to help preserve muscle during weight loss.
• Duration: Weight regain is common after discontinuation, so long-term planning should be discussed with the patient.

Lifestyle and Nutrition Support

Medication is an adjunct to, not a replacement for, nutrition and activity counseling. Providers may also identify and address nutrient needs, particularly when intake is reduced.

Monitoring

• Weight, blood pressure, and tolerability at regular follow-up visits
• Glycemic markers and lipids, with medication adjustments as needed
• Hydration, nutrition adequacy, and gastrointestinal symptoms
• Reassessment of continued need and benefit

Hormonal Considerations

In some patients, symptoms related to menopause or testosterone deficiency may coexist with weight gain. Hormone status can be evaluated as part of a comprehensive workup, and treatment decisions are made by the licensed provider based on clinical criteria.